J&J at first will focus on surgical video, telepresence and planning and limit access to select hospitals. It plans to make the platform more widely available in 2025.
J&J creates open digital platform for surgical applications Read More »
Medicaid unwinding has been less than perfect. However, the process has helped states expand Medicaid eligibility to more people and streamline enrollment and outreach, according to a new survey.
States using unwinding lessons to improve Medicaid: KFF Read More »
While Thursday’s label expansion and traditional approval for the gene therapy is an important milestone, many challenges still face the Duchenne muscular dystrophy community.
Expanded Approval of Sarepta’s Elevidys Is Progress, But More Needed for DMD Patients Read More »
Los vehículos autónomos, una vez relegados a la ciencia ficción, están cada vez más cerca de convertirse en una realidad cotidiana. Exploremos el desarrollo de estos innovadores automóviles y su integración en la sociedad, analizando los avances tecno …
El desarrollo de vehículos autónomos y su integración en la sociedad Read More »
Demócrito de Abdera, un nombre que resuena en los anales de la filosofía y la ciencia antigua, es conocido como el “Padre de la Teoría Atómica”. Nacido en el siglo V a.C. en Abdera, Tracia, Demócrito revolucionó la comprensión del universo c …
Alivexis, Inc. and Melodia Therapeutics AG, a company established by Forty51 Ventures, announced that they have entered into an exclusive license agreement for the worldwide development, manufacturing, and commercialization of Alivexis’ MDI-0151, a novel Cathepsin C inhibitor with best-in-class potential.
Ascentage Pharma, a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B, and age-related diseases, announced that the agreed equity investment by Takeda has been closed on June 20, 2024, with all proceeds already received.
Ascentage Pharma Announces Closing of US$75 Million Equity Investment by Takeda Read More »
CureDuchenne, a global nonprofit committed to finding and funding a cure for Duchenne muscular dystrophy, will host webinars in English and Spanish for the Duchenne community after the U.S. Food and Drug Administration approved the expansion to the label indication for ELEVIDYS from Sarepta Therapeutics to include individuals with Duchenne muscular dystrophy with a confirmed
El atractivo del bingo online: entretenimiento digital en 2024 En la era digital actual, BingoOnlineES.com ha emergido como una forma vibrante y emocionante de entretenimiento, capturando la atención de millones de personas en todo el mundo. ¿Qué es lo que hace que este …
¿Por qué el bingo online será un pasatiempo popular en 2024? Read More »
AriBio Co., Ltd. announces the expansion of testing for Alzheimer’s disease by entering into a strategic collaboration with Kentucky Clinical Trial Laboratory for the testing of cerebral spinal fluid to accurately and efficiently aid in the diagnosis of Alzheimer’s disease using the Lumipulse® system from FujireBio.
